SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-03-25 12:35
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Lee, Danny Wayne Kent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$90,000
+300,000 vol
$0.30 each
700,000
Filed 2021-03-23 19:26
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$15,000
+50,000 vol
$0.30 each
1,878,571
Filed 2021-03-23 11:03
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$15,000
+50,000 vol
$0.30 each
350,000
Filed 2021-03-23 11:01
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$300,000
+1,000,000 vol
$0.30 each
1,000,000
Filed 2021-03-23 11:00
Tx date 2020-12-30
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-22 13:09
Tx date 2021-03-22
$GENX
Genix Pharmaceuticals Corporation
Yea, Darryl
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$240,000
+800,000 vol
$0.30 each
1,100,000
Filed 2021-02-04 13:34
Tx date 2021-01-29
$GENX
Genix Pharmaceuticals Corporation
Lewin, Jamie A.
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
$36,000
+150,000 vol
$0.24 each
150,000
Filed 2021-02-04 13:29
Tx date 2019-03-11
$GENX
Genix Pharmaceuticals Corporation
Lewin, Jamie A.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-31 16:40
Tx date 2020-12-30
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$340,086
+6,801,737 vol
$0.05 each
9,601,110
Filed 2020-12-31 16:38
Tx date 2020-12-30
$GENX
Genix Pharmaceuticals Corporation
Chow, Paul
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,799,373
Filed 2020-12-23 17:43
Tx date 2020-12-14
$GENX
Genix Pharmaceuticals Corporation
Lee, Danny Wayne Kent
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$88,000
+400,000 vol
$0.22 each
400,000
Filed 2020-12-23 17:41
Tx date 2020-12-14
$GENX
Genix Pharmaceuticals Corporation
Lee, Danny Wayne Kent
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-21 19:39
Tx date 2020-09-18
$GENX
Genix Pharmaceuticals Corporation
Yea, Darryl
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$90,000
+300,000 vol
$0.30 each
300,000
Filed 2020-09-21 19:36
Tx date 2020-09-18
$GENX
Genix Pharmaceuticals Corporation
Yea, Darryl
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-21 19:32
Tx date 2020-09-18
$GENX
Genix Pharmaceuticals Corporation
Yea, Darryl
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-21 19:29
Tx date 2020-09-18
$GENX
Genix Pharmaceuticals Corporation
Yea, Darryl
4 - Director of Issuer
Holder: Investco Capital Management (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2020-08-13 18:13
Tx date 2020-08-06
$GENX
Genix Pharmaceuticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$90,000
+300,000 vol
$0.30 each
300,000
Filed 2020-08-13 18:11
Tx date 2019-08-01
$GENX
Genix Pharmaceuticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-13 14:16
Tx date 2020-07-03
$GENX
Genix Pharmaceuticals Corporation
Lewin, Jamie A.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+450,000 vol
450,000
Filed 2020-08-13 14:12
Tx date 2019-03-11
$GENX
Genix Pharmaceuticals Corporation
Lewin, Jamie A.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-12 14:35
Tx date 2020-08-10
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$90,000
+300,000 vol
$0.30 each
1,828,571
Filed 2020-08-12 14:16
Tx date 2018-08-27
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
1,528,571
Filed 2020-07-23 12:32
Tx date 2020-07-21
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$21,000
+100,000 vol
$0.21 each
1,528,571
Filed 2020-07-23 12:32
Tx date 2020-07-21
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-210,000
-1,000,000 vol
$0.21 each
1,428,571
Filed 2020-07-23 12:29
Tx date 2020-07-21
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$210,000
+1,000,000 vol
$0.21 each
2,428,571
Filed 2020-07-23 12:27
Tx date 2018-08-27
$GENX
Genix Pharmaceuticals Corporation
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,428,571
Filed 2020-01-22 17:20
Tx date 2020-01-22
$GENX
Genix Pharmaceucticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$400.00
+5,000 vol
$0.08 each
5,000
Filed 2020-01-22 17:20
Tx date 2019-08-01
$GENX
Genix Pharmaceucticals Corporation
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report